Bringing the fundamentals into focus…
Back to The Oncology Institute, Inc.
How The Oncology Institute, Inc. stacks up
STLN · against 481 other Healthcare companies of similar size
Profitability
20/ 100
Near the bottom of its peers.
Ranked #393 of 482 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score54 peers with a profitability score of 20–29, including STLN · Click a bar to see the companies
Why profitability scores 20?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 95% of peers. Return on invested capital: -148.7% vs peer median 4.7%
- a thinner operating margin: weaker than 70% of peers. Operating margin: -4.4% vs peer median 7.1%
- a higher return on assets: stronger than 100% of peers. Return on assets: 34017.4% vs peer median 1.7%
Metric by metric
Position: dot = STLN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | STLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 456 reported | -148.7% | 2.6% | 4% | 33% | |
| Operating marginHigher is better · 452 reported | -4.4% | 4.9% | 32% | 33% | |
| Return on assetsHigher is better · 477 reported | 34017.4% | 1.0% | 100% | 33% | |
| Return on equityHigher is better · 457 reported | Not reported | 1.6% | — | — | Context only |
| Gross marginHigher is better · 498 reported | 15.7% | 42.6% | 20% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around STLN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 388 | 560M USD | 21 | 42 | |
| 388 | 365M USD | 21 | 41 | |
| 388 | 486M USD | 21 | 16 | |
| 388 | 375M USD | 21 | 46 | |
| 393 | 646M USD | 20 | 46 | |
| 394 | 815M USD | 19 | 53 | |
| 394 | 647M USD | 19 | 40 | |
| 394 | 441M USD | 19 | 34 | |
| 394 | 758M USD | 19 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score